Domov › Rak (vse vrste) › Florida › Tampa
Klinične študije za Rak (vse vrste) v Tampa, FL
39 študij za Rak (vse vrste) išče udeležence na lokacijah v Tampa in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 2/3
- Moffitt Cancer Center /ID# 276785, Tampa
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Vključevanje udeležencevFaza 1
- Moffit Cancer Center, Tampa
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Vključevanje udeležencevFaza 1
- Moffitt Cancer Center /ID# 279068, Tampa
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Vključevanje udeležencevOpazovalna študija
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Vključevanje udeležencevOpazovalna študija
- Moffitt Cancer Center, Tampa
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Vključevanje udeležencevFaza 1
- Moffit Cancer center, Tampa
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Moffitt Cancer Center /ID# 279732, Tampa
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Vključevanje udeležencevFaza 1/2
- Moffitt Cancer Center and Research Institute, Tampa
Prospective Study to Assess a Diagnostic Aid for Cancer
Vključevanje udeležencevOpazovalna študija
- Avita Clinical Research, Tampa
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
Vključevanje udeležencevOpazovalna študija
- Moffitt Cancer Center, Tampa
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Vključevanje udeležencevFaza 2/3
- USF Health Morsani Center for Advanced Healthcare, Tampa
- H. Lee Moffitt Cancer Center and Research Institute University of South Florida, Tampa
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Vključevanje udeležencevFaza 2
- University of South Florida, Department of Psychiatry and Behavioral Neuroscience, Tampa
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Vključevanje udeležencevFaza 1/2
- Moffitt Cancer Center, Tampa
Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Moffitt Cancer Center, Tampa
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Moffitt Cancer Center, Tampa
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Vključevanje udeležencevFaza 1
- Moffitt Cancer Center, Tampa
Project: Every Child for Younger Patients With Cancer
Vključevanje udeležencevOpazovalna študija
- Tampa General Hospital, Tampa
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Vključevanje udeležencevFaza 3
- Moffitt Cancer Center, Tampa
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Moffitt Cancer Center, Tampa
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Vključevanje udeležencevFaza 1/2
- Moffitt Cancer Center /ID# 272628, Tampa
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Vključevanje udeležencevFaza 2
- Moffitt Cancer Center /ID# 274372, Tampa
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Moffitt Cancer Center, Tampa
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Vključevanje udeležencevFaza 2
- Moffitt Cancer Center, Tampa
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Vključevanje udeležencevFaza 1/2
- H Lee Moffitt Cancer Center and Research Institute, Tampa
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Vključevanje udeležencevFaza 1/2
- Moffitt Cancer Center, Tampa
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Vključevanje udeležencevFaza 1/2
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Vključevanje udeležencevFaza 1/2
- Moffitt Cancer Center and Research Institute, Tampa
Galleri® in the Medicare Population.
Vključevanje udeležencevVabljeni zdravi prostovoljci
- USF Morsani Center for Advanced Healthcare, Tampa
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Moffitt Cancer Center, Tampa
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Vključevanje udeležencevFaza 2
- H. Lee Moffitt Cancer Center and Research Institute, Tampa
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Vključevanje udeležencevFaza 2
- Moffitt Cancer Center, Tampa
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Vključevanje udeležencevFaza 1
- Moffitt Cancer Center, Tampa
Beat Childhood Cancer Specimen Banking and Data Registry
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- St. Joseph's Children's Hospital, Tampa
Caris Biorepository Research Protocol
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- The University of South Florida, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Tampa
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Vključevanje udeležencev
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Vključevanje udeležencevFaza 1/2
- Moffitt Cancer Center, Tampa
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Vključevanje udeležencev
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Magnolia Campus, Tampa
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Vključevanje udeležencevFaza 1/2
- Moffitt Cancer Center, Tampa
Študije za Rak (vse vrste) v drugih mestih
- Houston, TX121 študij
- New York City, NY109 študij
- Boston, MA85 študij
- Los Angeles, CA74 študij
- Nashville, TN65 študij
- Philadelphia, PA59 študij
- Washington, DC58 študij
- Durham, NC58 študij
- Chicago, IL51 študij
- Atlanta, GA49 študij
- Seattle, WA49 študij
- Arlington, VA48 študij
Druge študije v Tampa
- Nemalicelični pljučni rak51 študij
- Rak dojke43 študij
- Kolorektalni rak34 študij
- Akutna mieločna levkemija29 študij
- Metastatski rak29 študij
- Rak pljuč29 študij
- Rak trebušne slinavke26 študij
- Rak jajčnikov21 študij
- Melanom19 študij
- Mielodisplastični sindromi19 študij
- Rak prostate18 študij
- Srčno popuščanje18 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.